Breaking
RAPS Euro Convergence 2026: Regulatory News - Day 1 RoundupHeart Failure 2026: Vutrisiran Data & European Pharma NewsMifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling
🇪🇺 EMA

Longevity

Page 1 • 1 item

Unlock global longevity market insights. Discover pharma R&D, investment trends, and regulatory shifts shaping the future of aging therapeutics.

Seragon's SRN-901 Longevity Drug Shows Significant Lifespan Extension in Preclinical Study
NewsLongevity/Anti-agingApr 16, 2026

Seragon's SRN-901 Longevity Drug Shows Significant Lifespan Extension in Preclinical Study

Seragon Biosciences' SRN-901 demonstrated significant lifespan and healthspan extension in mice, marking a breakthrough in longevity therapeutics development.

Dr. Elena Rossi